The relevance of TERE1 loss to the elevated cholesterol phenotype of advanced prostate cancer is further based on previous studies from our laboratory and others that have demonstrated the role of TERE1 as a central modulator of cholesterol homeostasis, at the nexus of cholesterol synthesis, storage and efflux. This evidence concerns the gene UBIAD1 and prostate cancer.